These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16886951

  • 1. Obesity and polycystic ovary syndrome.
    Barber TM, McCarthy MI, Wass JA, Franks S.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):137-45. PubMed ID: 16886951
    [Abstract] [Full Text] [Related]

  • 2. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R, Gambineri A, Pagotto U.
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [Abstract] [Full Text] [Related]

  • 3. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E.
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [Abstract] [Full Text] [Related]

  • 4. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 5. Abdominal adiposity and the polycystic ovary syndrome.
    Escobar-Morreale HF, San Millán JL.
    Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
    [Abstract] [Full Text] [Related]

  • 6. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Sep; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 7. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [Abstract] [Full Text] [Related]

  • 8. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF, Nilas L, Nørgaard K, Jensen JE, Madsbad S.
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [Abstract] [Full Text] [Related]

  • 9. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 10. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F, Palomba S, Vigorito C, Tafuri MG, Colao A, Lombardi G, Orio F.
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovary syndrome in adolescents.
    Franks S.
    Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
    [Abstract] [Full Text] [Related]

  • 12. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 13. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S, McCarthy MI, Hardy K.
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [Abstract] [Full Text] [Related]

  • 14. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.
    Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
    [Abstract] [Full Text] [Related]

  • 15. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M, Migliavacca R, Sisson de Castro JA, Spritzer PM.
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [Abstract] [Full Text] [Related]

  • 16. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 17. The role of low-grade inflammation in the polycystic ovary syndrome.
    Repaci A, Gambineri A, Pasquali R.
    Mol Cell Endocrinol; 2011 Mar 15; 335(1):30-41. PubMed ID: 20708064
    [Abstract] [Full Text] [Related]

  • 18. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec 15; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E.
    Expert Rev Mol Med; 2008 Jan 30; 10():e3. PubMed ID: 18230193
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct 30; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.